306 related articles for article (PubMed ID: 21896136)
1. Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides.
Kiripolsky MG; Goldman MP
J Cosmet Dermatol; 2011 Sep; 10(3):232-4. PubMed ID: 21896136
[TBL] [Abstract][Full Text] [Related]
2. A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides.
Fabi SG; Sundaram H; Guiha I; Goldman MP
J Drugs Dermatol; 2013 Aug; 12(8):932-7. PubMed ID: 23986168
[TBL] [Abstract][Full Text] [Related]
3. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
Kiripolsky MG; Peterson JD; Guiha I; Goldman MP
Dermatol Surg; 2011 Oct; 37(10):1443-7. PubMed ID: 21649790
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
Sepehr A; Chauhan N; Alexander AJ; Adamson PA
Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH
J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
[TBL] [Abstract][Full Text] [Related]
6. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
Beer KR; Wilson F
Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
[No Abstract] [Full Text] [Related]
7. A Prospective, Neurophysiologic Comparative Study to Assess the Efficacy and Duration of Effect of IncobotulinumtoxinA and AbobotulinumtoxinA in the Treatment of Crow's Feet.
Saybel A; Artemenko A; Nikitin S; Kurenkov A
J Drugs Dermatol; 2015 Nov; 14(11):1291-6. PubMed ID: 26580879
[TBL] [Abstract][Full Text] [Related]
8. Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.
Cohen JL; Scuderi N
Aesthet Surg J; 2017 May; 37(suppl_1):S32-S44. PubMed ID: 28388721
[TBL] [Abstract][Full Text] [Related]
9. Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA.
Yu KC; Nettar KD; Bapna S; Boscardin WJ; Maas CS
Arch Facial Plast Surg; 2012; 14(3):198-204. PubMed ID: 22183059
[TBL] [Abstract][Full Text] [Related]
10. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
11. Dry eyes and superficial punctate keratitis: a complication of treatment of glabelar dynamic rhytides with botulinum exotoxin A.
Northington ME; Huang CC
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1515-7. PubMed ID: 15606828
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
[TBL] [Abstract][Full Text] [Related]
13. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
West TB
Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
[No Abstract] [Full Text] [Related]
14. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
Carruthers J; Carruthers A; Monheit GD; Davis PG
Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet.
Guerrissi JO
Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):161S-163S. PubMed ID: 14504499
[No Abstract] [Full Text] [Related]
16. Introduction to the Supplement: A Review of AbobotulinumtoxinA (Dysport).
Dover JS
Aesthet Surg J; 2017 May; 37(suppl_1):S1-S3. PubMed ID: 28388716
[No Abstract] [Full Text] [Related]
17. Botulinum toxin injection for facial wrinkles.
Small R
Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
[TBL] [Abstract][Full Text] [Related]
18. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
Iozzo I; Tengattini V; Antonucci VA
J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
[TBL] [Abstract][Full Text] [Related]
19. The use of botulinum toxin type A in cosmetic facial procedures.
Jaspers GW; Pijpe J; Jansma J
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
[TBL] [Abstract][Full Text] [Related]
20. Cosmetic uses of botulinum neurotoxin type A: an overview.
Blitzer A; Binder WJ
Arch Facial Plast Surg; 2002; 4(4):214-20. PubMed ID: 12437425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
